Novo Nordisk
NVO
#97
Rank
HK$1.534 T
Marketcap
HK$346.24
Share price
-1.71%
Change (1 day)
-37.29%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): HK$195.62 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$51.37 Billion. In 2025 the company made an earning of HK$164.23 Billion, an increase over its 2024 earnings that were of HK$154.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$195.62 B19.11%
2025 HK$164.23 B6.28%
2024 HK$154.52 B28.01%
2023 HK$120.71 B57.81%
2022 HK$76.49 B5.24%
2021 HK$72.68 B12.38%
2020 HK$64.68 B13.11%
2019 HK$57.18 B-3.45%
2018 HK$59.22 B1.88%
2017 HK$58.13 B4.3%
2016 HK$55.73 B10.32%
2015 HK$50.51 B7.47%
2014 HK$47.00 B3.4%
2013 HK$45.46 B19.09%
2012 HK$38.17 B15.58%
2011 HK$33.03 B16.58%
2010 HK$28.33 B25.66%
2009 HK$22.54 B10.68%
2008 HK$20.37 B55.82%
2007 HK$13.07 B7.02%
2006 HK$12.21 B19.05%
2005 HK$10.26 B10.55%
2004 HK$9.28 B
2002 HK$6.46 B-14.39%
2001 HK$7.55 B-52.82%
2000 HK$16.00 B250%
1999 HK$4.57 B31.21%
1998 HK$3.48 B34.31%
1997 HK$2.59 B11.46%
1996 HK$2.32 B9.03%
1995 HK$2.13 B-3.15%
1994 HK$2.20 B-0.67%
1993 HK$2.21 B45.38%
1992 HK$1.52 B-13.81%
1991 HK$1.77 B37.12%
1990 HK$1.29 B-0.79%
1989 HK$1.30 B26.2%
1988 HK$1.03 B24.97%
1987 HK$0.82 B-0.9%
1986 HK$0.83 B-7.78%
1985 HK$0.90 B24.87%
1984 HK$0.72 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$82.98 B-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$243.87 B 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.00 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$75.19 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA